SCHEMBL16459782

SCHEMBL16459782

C[Si](C)(Cc1ccccc1)O[SiH2]Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.34
AOC3 Q16853 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
MC4R P32245 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
CYP19A1 P11511 2/20 0.32
ELANE P08246 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
TBXAS1 P24557 1/20 0.32
QPCT Q16769 1/20 0.32
CYP4Z1 Q86W10 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16460750 0.77 TP53 (0.37) TSHRTP53CYP19A1ELANECALM1
SCHEMBL243501 0.77 TSHR (0.39) TSHRALDH1A1TP53AOC3NR1H2
SCHEMBL5388447 0.76 TSHR (0.42) TSHRALDH1A1TP53AOC3NR1H2
SCHEMBL109029 0.74 TSHR (0.41) TSHRALDH1A1TP53AOC3NR1H2
SCHEMBL1107767 0.73 TP53 (0.48) TSHRALDH1A1TP53NR1H2NR1H3
SCHEMBL13550868 0.72 TSHR (0.39) TSHRALDH1A1TP53AOC3NR1H2
SCHEMBL14665751 0.72 TSHR (0.39) TSHRALDH1A1TP53AOC3NR1H2
SCHEMBL14689277 0.72 TP53 (0.34) TSHRTP53NR1H2NR1H3CYP19A1
SCHEMBL1271761 0.72 TP53 (0.42) TSHRALDH1A1TP53NR1H2NR1H3
SCHEMBL109170 0.71 TP53 (0.42) TSHRALDH1A1TP53AOC3NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303059-B2 Chemoselective enrichment for compound isolation INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2016-04-05 US disclosed
US-20140107328-A1 CHEMOSELECTIVE ENRICHMENT FOR COMPOUND ISOLATION INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107328-A1 CHEMOSELECTIVE ENRICHMENT FOR COMPOUND ISOLATION PAH, HAAO, APEH TSHR 4644/4885ALDH1A1 417/4885TP53 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.